South Africa: Regulating Everything Medical

Last Updated: 26 October 2011
Article by Neil Kirby

The draft regulations were published in the Government Gazette on 22 July 2011 (under notice 586 in Government Gazette No. 34463) for public comment. The three month period for public comment expired on or about 22 September 2011.

Regulations relating to medical devices

The proposed regulations consist of two sets of regulations. The first deals with regulations relating to medical devices. This set stands independently from regulations already in place under the Medicines and Related Substances Act No. 101 of 1965, as amended (the Medicines Act).

The scope and ambit of the regulations is dependant largely on whether or not a particular item falls within one of the eight categories of medical devices that are identified in proposed regulation 2. In so far as an item does fall within one of the categories, the item must be registered within that category as a medical device with the Medicines Control Council (the MCC).

The categories that have been published for comment are as follows:

" (a) Category C1: non-invasive medical devices which do not penetrate the body;

(b) Category C2: invasive medical devices that in whole or in part, penetrate the body, either through a body orifice or through the surface of the body;

(c) Category C3: active medical devices whose operation depend on a source of electrical energy or any source of power other than that directly generated by the human body or gravity and which acts by converting energy;

(d) Category C4: combination medical devices that incorporate, as an integral part, a substance which, if used separately, can be considered to be a medicine, and which act son [sic] the human body with action ancillary to that of the medical device;

(e) Category C5: medical devices that are manufactured from or incorporating animal with human cell, tissue [sic] or derivative thereof;

(f) Category C6: medical devices used for sterilising or disinfecting other medical devices;

(g) Category C7: medical devices used for contraception or the prevention of the transmission of sexually transmitted diseases; and

(h) Category C8: in vitro diagnostic medical devices which, whether used alone or in combination, are intended by the manufacturer for the in vitro examination of specimens derived from the human body solely or principally to provide information for diagnostic, monitoring or compatibility purposes".

The legal obligation to register a medical device will become operative once the final regulations are published. In terms of proposed regulation 4(1), the sale of an unregistered medical device will become prohibited.

The legal obligation to register a medical device will arise under proposed regulation 2. However, it is not clear whether or not the proposed regulations are to apply retrospectively to devices that are already in the marketplace and in use and where no sale occurs as contemplated in proposed regulation 4(1).

The proposed regulations endeavour to create a system of regulation in terms of which the MCC will determine which categories of medical devices are to be registered. Presumably, the MCC will issue a call-up notice, pursuant to proposed regulation 4(2), and require that category of medical devices to become registered.

In this regard, the resolution by the MCC will, in all likelihood, be published in the Government Gazette timeously under the direction of the Registrar of Medicines. Once such a publication occurs, an application for the registration of a medical device will have to be submitted to the MCC in accordance with the provisions and detailed contained in proposed regulation 5.

In terms of proposed regulation 6, manufacturers, importers or local representatives of such manufacturers of medical devices will have two years from the date that the regulations become effective to provide specified information to the Registrar of Medicines.

This information is set out in proposed regulations 6(1)(a) to (g) and includes the following:

" (a) name of the manufacturer or importer;

(b) address of [the] manufacturer or importer;

(c) name of [the] medical device;

(d) unique identification number, where practicable [of the medical device];

(e) [the] number [applied to medical device] according to an internationally recognised device nomenclature system as approved by the Council;

(f) category or class of medical device; and

(g) brief description of the medical device and its use".

Once the information is supplied to the Registrar, the Registrar will then allocate the medical device a number in accordance with proposed regulation 6(2). The number is not a registration, but rather recognition by the MCC of the existence of the device in the Republic.

Proposed regulation 6(4) allows the MCC to impose particular requirements on that medical device, which are currently unknown, "in order to ensure that the medical device is safe and of good quality".

The balance of the proposed regulations endeavour to align the control of medical devices with the manner of regulatory control already imposed by the Medicines Act on medicines.

Therefore, further proposed regulations deal with:

  • amending and updating registration details;
  • transferring certificates of registration;
  • licensing manufacturers,
  • exporters and importers; the duties of licence holders; and
  • cancelling a registration or licence.

Particular provision is also made for combination devices in proposed regulation 7.

Advertisements and promotions will be particularly controlled in terms of proposed regulation 13. In terms of proposed regulation 13(2), the MCC may prohibit the promotion or restrict the advertisement of certain medical devices "to the general public".

Proposed regulations for labelling and instructions for use for medical devices are contained in proposed regulation 14.

The manner in which medical devices are to be disposed of is outlined in proposed regulation 18.

In terms of proposed regulation 17, the MCC is afforded power to recall medical devices and specific duties are imposed upon persons using medical devices in health establishments. In this regard, the head of any health establishment attracts certain duties to ensure that the use of medical devices complies with the regulations in terms of proposed regulations 19 and 20.

In terms of proposed regulation 22 any person who contravenes the provisions of the proposed regulations, once final, is guilty of an offence. He or she will be liable for a fine and imprisonment for a period not exceeding five years or to both the fine and imprisonment.

Regulations relating to complementary medicines

Regulations concerning the control of complementary medicines are also proposed. However, these regulations are amendments to the existing general regulations in terms of the Medicines Act.

The scope and ambit of the amendments turn directly on the definition of "complementary medicine". A complementary medicine will be defined as follows:

"a medicine that is used –

  1. or intended to be used for, or manufactured or sold for use in assisting innate healing power of a human being or animal; and
  2. in accordance with the practice of the professions regulated under the Allied Health Professions Act, 1982 (Act No. 63 of 1982)" (emphasis added).

Complementary medicines fall within a category of medicines described as category D. Category D medicines are those in addition to the medicines or substances that are classified currently in categories A to C in terms of the General Regulations to the Medicines Act.

The introduction of formal regulations for complementary medicines is a significant step in the control of an extensive complementary medicines market in the Republic. Should the regulations proceed in their current format, complementary medicines - or substances falling within the four corners of the definition contained in the proposed regulations - will be subjected to the same process for registration as substances that fall into the existing categories A to C of the Medicines Act.

Therefore, complementary medicines will be treated in almost the same manner, from a regulatory and registration point of view, as is currently applicable to branded or allopathic medicines. Such a system of registration presents unique challenges for the purposes of controlling complementary medicines bearing in mind the broad nature of the types and variations of substances that fall within this category.

The one failing that is immediately noticeable is the division of complementary medicines into two distinct markets:

  • the first is the market defined by the definition contained in the proposed regulations, being the market dealt with and governed by the professions regulated under the Allied Health Professions Act No. 63 of 1982, and
  • the second is the market consisting of those complementary medicines that are used by professions not governed by the aforementioned Act or the Health Professions Act No. 56 of 1974, as amended.

The legality of such a definition will have to be carefully examined in relation to the principles of administrative law and the Constitution of the Republic of South Africa, 1996. This may produce the result that the definition of "complementary medicine", upon which legality of the balance of the regulations pertaining to complementary medicines rests, may be too vague for proper enforcement in terms of existing principles of South African law.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions